Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
san francisco blog main
boston blog main
boston top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
startups
acute myeloid leukemia
adverum biotechnologies
alder biopharmaceutical
allergan
alnylam pharmaceuticals
ambit biosciences
american academy of neurology
amgen
athena countouriotis
atogepant
beijing
biohaven
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brett zbar
brian abrahams
brii bio
brii biosciences
bristol-myers squibb
calcitonin gene-related peptide
china
clinical trials
cormorant asset management
daiichi sankyo
deals
detroit blog main
What
drug
4
×
new
4
×
year
4
×
class
companies
million
adds
alliance
amgen
approval
areas
arguments
athena
big
biosciences
biotech
bio’s
brii
called
cancer
ceo
chief
commercialized
competitors
conducted
countouriotis
crippling
days
decades
disease
drugs
earlier
erenumab
extra
fda
fewer
financing
gets
headaches
hepatitis
Language
Current search:
drug
×
year
×
new
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines
